509TiP REPROGRAM-01, a phase II study of regorafenib in combination with a multimodal metronomic chemotherapy in patients with metastatic colorectal cancer

509TiP REPROGRAM-01, a phase II study of regorafenib in combination with a multimodal metronomic chemotherapy in patients with metastatic colorectal cancer

Saved in:
Bibliographic Details
Published in:Annals of oncology Vol. 32; p. S581
Main Authors: Klajer, E., Jary, M., Borg, C., Kim, S., Vernerey, D., Henriques, J., N'Guyen, T., Nasri, M., Almotlak, H., Babre, J., Meurisse, A., Fratte, S., Fein, F., Calcagno, F., Chanut, L., Spehner, L., Rebucci-Peixoto, M., Vienot, A.
Format: Journal Article
Language:English
Published: Elsevier Ltd 01-09-2021
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0923-7534
1569-8041
DOI:10.1016/j.annonc.2021.08.1028